EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of Cerium Oxide/Chitosan/Graphene Oxide Nanocomposite: An Investigation toward Its Biological Applications under In Vitro Conditions

J. Saranya, S. Preethi, Mohammed Rafi Shaik, Merajuddin Khan, Mujeeb Khan, Baji Shaik

Crystals · 19.09.2023 · 13 (9) · 1393

DOI: 10.3390/cryst13091393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Crystals, online erschienen am 19.09.2023. Verfasst von J. Saranya und 5 weiteren Autor:innen. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University, Riyadh, Saudi Arabia.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A ternary nanocomposite was prepared using cerium oxide, chitosan, and graphene oxide (CeO2/CS/GO) using a simple and cost-effective wet chemical method. The physicochemical properties of the developed ternary nanocomposite were examined using X-ray diffraction, Fourier transform infrared spectroscopy, scanning electron microscopy with energy-dispersive X-ray spectroscopy, and ultraviolet-visible spectroscopy. Furthermore, the therapeutic behavior of the developed CeO2/CS/GO composite was assessed using anti-bacterial, anti-fungal, and anti-cancer assays. For Escherichia coli, Staphylococcus aureus, and Salmonella species, 750 µg/mL of the CeO2/CS/GO composite showed effective anti-bacterial activity, with a zone of inhibition of 9 mm. Additionally, the CeO2/CS/GO composite’s anti-fungal activity against Aspergillus niger was studied. The anti-cancer properties of different concentrations of the CeO2/CS/GO composite were assessed on MCF-7 cells, and 18.8% of cells were found to be viable at the maximum concentration of 1000 µg/mL CeO2/CS/GO and 46.37% at 125 µg/mL. The results of the hemolysis assay performed using human red blood cells and various concentrations of the CeO2/CS/GO composite indicated that the nanocomposite possesses biological properties. Overall, it can act as a therapeutic platform for breast cancer, bacterial and fungal infections.

Förderung

  • King Saud University, Riyadh, Saudi Arabia

Zitieren

APA

Saranya, J., Preethi, S., Shaik, M. R., Khan, M., Khan, M., & Shaik, B. (2023). Development of Cerium Oxide/Chitosan/Graphene Oxide Nanocomposite: An Investigation toward Its Biological Applications under In Vitro Conditions. Crystals, 13(9), 1393. https://doi.org/10.3390/cryst13091393

Vancouver

Saranya J, Preethi S, Shaik MR, Khan M, Khan M, Shaik B. Development of Cerium Oxide/Chitosan/Graphene Oxide Nanocomposite: An Investigation toward Its Biological Applications under In Vitro Conditions. Crystals. 2023;13(9):1393. doi:10.3390/cryst13091393

BibTeX
@article{Saranya2023,
  author = {Saranya, J. and Preethi, S. and Shaik, Mohammed Rafi and Khan, Merajuddin and Khan, Mujeeb and Shaik, Baji},
  title = {Development of Cerium Oxide/Chitosan/Graphene Oxide Nanocomposite: An Investigation toward Its Biological Applications under In Vitro Conditions},
  journal = {Crystals},
  year = {2023},
  volume = {13},
  number = {9},
  pages = {1393},
  doi = {10.3390/cryst13091393}
}
Kostenlos starten →